435 related articles for article (PubMed ID: 30661921)
21. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
Chen YT; Huang ZP; Zhou ZW; He MM
Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
Li X; Gou S; Liu Z; Ye Z; Wang C
Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
[TBL] [Abstract][Full Text] [Related]
23. A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer.
Li ZS; Ornellas AA; Schwentner C; Li X; Chaux A; Netto G; Burnett AL; Tang Y; Geng J; Yao K; Chen XF; Wang B; Liao H; Liu N; Chen P; Lei YH; Mi QW; Rao HL; Xiao YM; Wang QL; Qin ZK; Liu ZW; Li YH; Zou ZJ; Luo JH; Li H; Han H; Zhou FJ
Cancer Commun (Lond); 2018 Nov; 38(1):68. PubMed ID: 30470255
[TBL] [Abstract][Full Text] [Related]
24. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma.
Moeckelmann N; Ebrahimi A; Tou YK; Gupta R; Low TH; Ashford B; Ch'ng S; Palme CE; Clark JR
Oral Oncol; 2018 Oct; 85():82-86. PubMed ID: 30220324
[TBL] [Abstract][Full Text] [Related]
28. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
[TBL] [Abstract][Full Text] [Related]
29. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system.
Zhang R; Guo Y; Wang Y; Hu L; Fang C; Yang Y; Yang X; Chen L; Chen J; Wang W; Sun X
Cancer Med; 2023 Mar; 12(6):6623-6636. PubMed ID: 36394081
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
Lombardi A; Vitale V; Nigri G; Olivieri C; Mastrangeli MR; Bizzaglia E; Amanti C
Breast J; 2020 Jul; 26(7):1265-1269. PubMed ID: 32180300
[TBL] [Abstract][Full Text] [Related]
31. A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.
Seeruttun SR; Xu L; Wang F; Yi X; Fang C; Liu Z; Wang W; Zhou Z
Cancer Commun (Lond); 2019 Jun; 39(1):32. PubMed ID: 31182160
[TBL] [Abstract][Full Text] [Related]
32. Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors.
Yang M; Zeng L; Hou S; Tian B; Jin S; Zhang Y
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142900
[TBL] [Abstract][Full Text] [Related]
33. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
[TBL] [Abstract][Full Text] [Related]
34. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.
Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E
J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375
[TBL] [Abstract][Full Text] [Related]
35. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
Li HJ; Chen YT; Yuan SQ
Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
[TBL] [Abstract][Full Text] [Related]
36. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
[TBL] [Abstract][Full Text] [Related]
37. Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms.
Shi H; Chen L; Zhang Q; Lin Y; Jiang C; Yao H; Hou X; Chen M; Lin R; Chen J
Pancreas; 2020; 49(10):1378-1382. PubMed ID: 33122528
[TBL] [Abstract][Full Text] [Related]
38. Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade.
König AK; Gros H; Hinz U; Hank T; Kaiser J; Hackert T; Bergmann F; Büchler MW; Strobel O
Eur J Surg Oncol; 2022 Jan; 48(1):113-120. PubMed ID: 34344573
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
Kim BS; Park YS; Yook JH; Kim BS
Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
[TBL] [Abstract][Full Text] [Related]
40. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
